ICS/LABA Adherence and COPD Exacerbation

Trial Identifier: D589BR00034
Sponsor:AstraZeneca
Collaborator:
Healthcore
NCTID:NCT02446041
Start Date:May 2015
Primary Completion Date: October 2015
Study Completion Date: October 2015
Condition: Immune, Inflammatory & Infections - Other; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
USA, DE Wilmington, DE, USA